Abstract is: Ipratropium bromide, sold under the trade name Atrovent among others, is a type of anticholinergic (SAMA: short acting muscarinic antagonist), medication which opens up the medium and large airways in the lungs. It is used to treat the symptoms of chronic obstructive pulmonary disease and asthma. It is used by inhaler or nebulizer. Onset of action is typically within 15 to 30 minutes and lasts for three to five hours. Common side effects include dry mouth, cough, and inflammation of the airways. Potentially serious side effects include urinary retention, worsening spasms of the airways, and a severe allergic reaction. It appears to be safe in pregnancy and breastfeeding. Ipratropium is a short-acting muscarinic antagonist, which works by causing smooth muscles to relax. Ipratropium bromide was patented in 1966, and approved for medical use in 1974. It is on the World Health Organization's List of Essential Medicines, the most important medicines needed in a health system. Ipratropium is available as a generic medication. In 2020, it was the 312th most commonly prescribed medication in the United States, with more than 900 thousand prescriptions.
| P4250 | defined daily dose | 0.24 | |
| P527 | has part(s) | hydrogen | Q556 |
| carbon | Q623 | ||
| nitrogen | Q627 | ||
| oxygen | Q629 | ||
| bromine | Q879 | ||
| P366 | has use | medication | Q12140 |
| P2067 | mass | 411.14090591999997 | |
| P3489 | pregnancy category | US pregnancy category B | Q28123616 |
| P2868 | subject has role | essential medicine | Q35456 |
| Q72774130 | A Comparative Study of Various Combinations of Ipratropium Bromide and Metaproterenol in Allergic Asthmatic Patients |
| Q72239896 | A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis |
| Q67840305 | A comparative study of bronchodilator actions of ipratropium bromide (atrovent) & salbutamol (ventolin) on exercise induced bronchial asthma |
| Q53955200 | A comparative study of two parasympatholytic bronchodilator agents: ipratropium bromide and diphemanil methylsulfate. |
| Q70012185 | A comparative trial of ipratropium bromide (Atrovent), controlled release theophylline (Phyllocontin), and a combination of these in patients with reversible airflow obstruction |
| Q36704980 | A comparison between a combination of ipratropium bromide plus fenoterol in a single metered dose inhaler (Duovent) and salbutamol in asthma |
| Q72816050 | A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol |
| Q83347088 | A comparison of in vitro relaxant responses to ipratropium bromide, β-adrenoceptor agonists and theophylline in feline bronchial smooth muscle |
| Q39814491 | A comparison of ipratropium bromide, deptropine citrate and placebo in asthma and chronic bronchitis |
| Q72764617 | A comparison of ketotifen with clemastine, ipratropium bromide and sodium cromoglycate in exercise-induced asthma |
| Q70006555 | A comparison of metered dose inhalers with nebulizers from the delivery of ipratropium bromide in domiciliary practice |
| Q72807459 | A comparison of oxitropium bromide and ipratropium bromide in asthma |
| Q35826716 | A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma. |
| Q70010833 | A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence |
| Q71562954 | A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease |
| Q68428754 | A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD |
| Q44471417 | A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. |
| Q43480151 | A comparison of three high doses of ipratropium bromide in chronic asthma |
| Q68435427 | A compounded treatment for watery rhinorrhea: ipratropium bromide solution |
| Q72816046 | A dose-response and duration of action assessment of a combined preparation of fenoterol and ipratropium bromide (Duovent) |
| Q72239903 | A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold |
| Q39498249 | A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold |
| Q33754508 | A meta-analysis of the effects of ipratropium bromide in adults with acute asthma |
| Q46737695 | A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats |
| Q69976607 | A place for ipratropium bromide in the treatment of severe acute asthma |
| Q70064329 | A placebo-controlled comparison between the bronchodilatory effects of ipratropium bromide inhaled as a dry powder and by metered dose inhaler in chronic obstructive pulmonary disease |
| Q39771940 | A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma |
| Q72774127 | A therapeutic comparison of ipratropium bromide and salbutamol in asthmatic patients |
| Q73359337 | A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis |
| Q51859157 | Actions of Theophylline, Terbutaline, and Ipratropium Bromide Alone and in Combinations on the Methacholine Induced Bronchoconstriction in Rats |
| Q42767062 | Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol |
| Q43013010 | Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol |
| Q64959004 | Acute angle closure glaucoma occurring after nebulized bronchodilator treatment with ipratropium bromide and salbutamol |
| Q36747722 | Acute angle-closure glaucoma as a complication of combined beta-agonist and ipratropium bromide therapy in the emergency department |
| Q28326662 | Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease |
| Q39794055 | Acute bronchodilator effect of chinoxaline, prednisolone, ipratropium bromide and fenoterol tested by whole-body plethysmography (author's transl) |
| Q70026640 | Acute controlled study of the dose-response relationship of fenoterol, ipratropium bromide and their combination |
| Q72794861 | Acute effect of ipratropium bromide at therapeutic dose on mucus transport of adult asthmatics |
| Q70056157 | Acute effects of fenoterol (Berotec) and ipratropium bromide (Atrovent) alone and in combination on bronchial hyperresponsiveness in asthmatic subjects |
| Q35940656 | Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies |
| Q68430096 | Additive effect of albuterol and ipratropium bromide in the treatment of bronchospasm in children |
| Q70010639 | Additive effects of isoproterenol-phenylephrine aerosol following ipratropium bromide on airway obstruction in older patients with intrinsic asthma and chronic bronchitis |
| Q72769042 | Adverse reaction to ipratropium bromide |
| Q93490537 | Adverse reaction to ipratropium bromide |
| Q92811932 | Aerosol Characteristics and Physico-Chemical Compatibility of Combivent® (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine |
| Q73726514 | Airway response of horses with COPD to dry powder inhalation of ipratropium bromide |
| Q69902795 | Airway response to salbutamol and to ipratropium bromide after non-selective and cardioselective beta-blocker |
| Q44842695 | Airways responses to ipratropium bromide do not vary with time in asthmatic subjects. Studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction |
| Q44361846 | An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease |
| Q70599299 | An unusual case of severe anaphylaxis due to ipratropium bromide inhalation |
| Q53552124 | Anisocoria with high dose ipratropium bromide inhaler. |
| Q43238627 | Anti-inflammatory effects of formoterol and ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats |
| Q56430421 | Antiallergic asthma effect of ipratropium bromide (Sch 1000) in dogs |
| Q36135849 | Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation |
| Q46077607 | Association of A/T polymorphism of the CHRM2 gene with bronchodilator response to ipratropium bromide in asthmatic children |
| Q39766307 | Asthma: Comparative Bronchodilator Effects of Ipratropium Bromide and Isoproterenol |
| Q43934213 | Benefits of ipratropium bromide in the management of asthmatic crises in the emergency department |
| Q47867873 | Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol. |
| Q28340385 | Bladder outflow obstruction induced by ipratropium bromide |
| Q28376953 | Blurred vision from ipratropium bromide inhalation |
| Q43503666 | Blurred vision from ipratropium bromide inhalation. |
| Q72835140 | Bronchial asthma in childhood. Therapy with fenoterol and ipratropium bromide powder |
| Q33603612 | Bronchial responsiveness to hyperventilation in children with asthma: inhibition by ipratropium bromide |
| Q39865925 | Bronchial spasmolytic action of terbutaline and fenoterol compared with that of ipratropium bromide in the anaesthetized dog |
| Q70060519 | Bronchoconstriction by nebulized metabisulfite solutions (SO2) and its modification by ipratropium bromide |
| Q34992319 | Bronchoconstriction in response to ipratropium bromide |
| Q72787290 | Bronchoconstriction in response to ipratropium bromide |
| Q43050284 | Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity |
| Q72824740 | Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity |
| Q45994275 | Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. |
| Q42056106 | Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion |
| Q34070101 | Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution |
| Q42125493 | Bronchodilating and density dependence effects of fenoterol, ipratropium bromide and Duovent in reversible chronic obstructive pulmonary disease |
| Q46893007 | Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD. |
| Q72252757 | Bronchodilating effect of ipratropium bromide in heart failure |
| Q67547067 | Bronchodilating effect of ipratropium bromide inhalation powder and aerosol in children and adolescents with stable bronchial asthma |
| Q70867440 | Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD |
| Q93881342 | Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD |
| Q72505284 | Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone |
| Q43947347 | Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD. |
| Q33970694 | Bronchodilator Action of the Anticholinergic Drug, Ipratropium Bromide (Sch 1000), as an Aerosol in Chronic Bronchitis and Asthma |
| Q70040272 | Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: use of MDI with a spacer device |
| Q35115218 | Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers |
| Q70026687 | Bronchodilator effect of the association ipratropium bromide plus fenoterol (low doses) versus terbutaline and salbutamol in bronchitic patients |
| Q35115528 | Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma |
| Q53762619 | Bronchodilator effects of ipratropium bromide and albuterol sulfate among subjects with tetraplegia. |
| Q54312764 | Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia. |
| Q68433476 | Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction |
| Q41153046 | Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease |
| Q44009808 | Bronchodilatory and circulatory effects of inhaling increasing doses of an anti-cholinergic drug, ipratropium bromide (SCH 1000) |
| Q71946259 | Bronchodilatory effects of ipratropium bromide in patients with tetraplegia |
| Q43628126 | Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: double-blind, placebo-controlled crossover study in cystic fibrosis |
| Q46052755 | Cardiovascular events associated with ipratropium bromide in COPD. |
| Q46233807 | Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium |
| Q28184711 | Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection |
| Q54547668 | Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols. |
| Q39324466 | Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat Soft Mist inhaler for relief of airflow obstruction |
| Q39904710 | Clinical experience with terbutaline sulphate and ipratropium bromide in bronchial asthma |
| Q70026647 | Clinical study on bronchodilation induced by a metered aerosol of fenoterol in combination with ipratropium bromide |
| Q43815320 | Cold-induced rhinitis in skiers--clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. |
| Q72255763 | Colored deposit left in endotracheal tubes by ipratropium bromide |
| Q72794854 | Combination of fenoterol and ipratropium bromide in the treatment of bronchial asthma |
| Q39770343 | Combined administration of ipratropium bromide (sch 1000) and fenoterol in patients with chronic obstructive airway disease (author's transl) |
| Q39881235 | Combined effect of an anticholinergic drug ipratropium bromide and disodium cromoglycate in exercise induced asthma |
| Q70026673 | Combined inhalation of fenoterol and ipratropium bromide in long-term therapy of chronic reversible airway obstruction |
| Q30472049 | Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection. |
| Q46734736 | Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma |
| Q69884474 | Combined treatment with ipratropium bromide and beta-2-adrenoceptor agonists in childhood asthma |
| Q73703336 | Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion |
| Q70060651 | Comparative cardiac effects of intravenous bolus of ipratropium bromide (itrop) and atropine sulfate in 22 patients |
| Q39913799 | Comparative clinical studies of beta-stimulating and anticholinergic broncho-dilators (trimethoquinol and ipratropium bromide) |
| Q46053057 | Comparative cost-effectiveness analysis of theophylline and ipratropium bromide in chronic obstructive pulmonary disease. A three-center study |
| Q45923606 | Comparative efficacy of combined nebulized salbutamol with ipratropium bromide and nebulized adrenaline to treat children with acute bronchiolitis. |
| Q39851649 | Comparative study of the efficacy and action duration of ipratropium bromide and atropine sulfate using His bundle-EG and tracing ECG in bradycardial arrhythmias |
| Q70062255 | Comparison between aerosol and powder delivery system of fenoterol plus ipratropium bromide ('Duovent') in patients with asthma and chronic bronchitis |
| Q52686450 | Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol |
| Q73109642 | Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea |
| Q72806280 | Comparison by double-blind study of the combination of an aerosol of salbutamol and ipratropium bromide and its individual effect in chronic bronchitis and bronchial asthma |
| Q59487680 | Comparison of Ipratropium Bromide and Albuterol Sulfate Chlorofluorocarbon Metered-Dose Inhaler and Albuterol Hydrofluoroalkane Metered-Dose Inhaler in a Crossover Trial in Patients with Moderate-to-Severe Asthma |
| Q93525312 | Comparison of a combination of fenoterol with ipratropium bromide (Duovent) and salbutamol in young adults with nocturnal asthma |
| Q44127590 | Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma |
| Q66892713 | Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma |
| Q70533585 | Comparison of atropine with ipratropium bromide in patients with reversible airways obstruction unresponsive to salbutamol |
| Q54075159 | Comparison of bronchodilatation produced by an anticholinergic (ipratropium bromide), a beta-2 adrenergic (fenoterol) and their combination in patients with chronic obstructive airway disease. An open trial |
| Q54386537 | Comparison of fenoterol, ipratropium bromide and their combination in patients with bronchial asthma. |
| Q70026695 | Comparison of fenoterol, ipratropium bromide, and their combination in patients with asthma or chronic airflow obstruction |
| Q68426503 | Comparison of inhaled terbutaline and inhaled terbutaline plus ipratropium bromide in acute asthmatic children |
| Q48744927 | Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children |
| Q28326665 | Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: A three-center study |
| Q39881226 | Comparison of ipratropium bromide and an oral anticholinergic drug in chronic bronchitis |
| Q39870987 | Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis |
| Q70563758 | Comparison of ipratropium bromide and salbutamol by aerosolized solution |
| Q39881239 | Comparison of ipratropium bromide and salbutamol in a long-term trial in asthmatic and bronchitic patients in a cold climate |
| Q44911361 | Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial |
| Q41231716 | Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease |
| Q83857616 | Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children |
| Q72789407 | Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma |
| Q44755813 | Comparison of protective effects induced by the ultrasonic mist of nicardipine + fenoterol versus nicardipine + fenoterol + ipratropium bromide |
| Q57934570 | Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma |
| Q70019041 | Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study |
| Q70026684 | Comparison of the bronchodilatation of ipratropium bromide and fenoterol nebuliser solutions administered alone and in combination |
| Q72660621 | Comparison of the bronchodilator efficacy of nebulized pirenzepine and ipratropium bromide in patients with airway obstructive lung disease |
| Q72538088 | Comparison of the bronchodilatory action and side-effects of ipratropium bromide and thiazinamium methyl sulphate: a long-term, double-blind, crossover trial in patients with chronic bronchitis |
| Q70037898 | Comparison of the effects of inhaled calcium antagonist verapamil, sodium cromoglycate and ipratropium bromide on exercise-induced bronchoconstriction in children with asthma |
| Q41128901 | Comparison of the effects of inhaled ipratropium bromide and salbutamol on the bronchoconstrictor response to hypocapnic hyperventilation in normal subjects |
| Q42170794 | Comparison of the effects of ipratropium bromide and salbutamol on autonomic heart rate control |
| Q77929435 | Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease |
| Q92365101 | Comparison of the efficacy of aerosol inhalation between the ipratropium bromide and terbutaline on the patients with AECOPD |
| Q36183570 | Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution |
| Q98617784 | Compatible Stability and Aerosol Characteristics of Atrovent® (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine |
| Q44419554 | Confusion and chorea triggered by the association of ipratropium bromide and salbutamol administered by inhaler |
| Q35157970 | Continuous Inhalation of Ipratropium Bromide for Acute Asthma Refractory to β2-agonist Treatment. |
| Q58863549 | Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease |
| Q70026677 | Controlled clinical study of a long-term treatment of chronic obstructive lung disease using a combination of fenoterol and ipratropium bromide in aerosol form |
| Q70533580 | Controlled trial of the effect of repeated administration of ipratropium bromide on ventilatory function of patients with severe chronic airways obstruction |
| Q44562769 | Cost effectiveness of the application of inhaled ipratropium bromide in the treatment of adult patients with acute asthma in Uruguay |
| Q70061667 | Cumulative dose-response curves for assessing combined effects of salbutamol and ipratropium bromide in chronic asthma |
| Q67904492 | Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to β-agonist therapy |
| Q93512073 | Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition |
| Q52081294 | Determination of ipratropium bromide in vials using kinetic and first-derivative spectrophotometric methods. |
| Q43203471 | Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution |
| Q83579297 | Development and validation of a stability-indicating high-performance liquid chromatography method for the simultaneous determination of albuterol, budesonide, and ipratropium bromide in compounded nebulizer solutions |
| Q41121154 | Direct labelling of ipratropium bromide aerosol and its deposition pattern in normal subjects and patients with chronic bronchitis |
| Q73759854 | Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department? |
| Q69988932 | Does ipratropium bromide by nebulizer and face-mask have local ocular effects? |
| Q54336339 | Dose effects of inhaled ipratropium bromide on the impedance of the respiratory system in normal subjects. |
| Q43860017 | Dose of nebulized ipratropium bromide in acute severe asthma |
| Q36180880 | Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma |
| Q41208962 | Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease |
| Q54625366 | Dose-effect study on the bronchospasmolytic drug ipratropium bromide in relation to blood gases and hemodynamics |
| Q36127672 | Dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulisation |
| Q54438568 | Dose-response relationship: fenoterol, ipratropium bromide and their combination. |
| Q46711993 | Double inhalation test with ipratropium bromide and salbutamol--assessment of its effects on partial and maximum expiratory flow-volume curves |
| Q67900839 | Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis |
| Q39799650 | Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator |
| Q33539871 | Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate |
| Q43867078 | Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients |
| Q70561267 | Early bronchodilating effect of oxitropium bromide in comparison with ipratropium bromide |
| Q70026663 | Effect of Duovent (ipratropium bromide and fenoterol) on non-specific bronchial hyperreactivity |
| Q39903197 | Effect of Ipratropium Bromide and Fenoterol on Airway Obstruction in Chronic Pulmonary Tuberculosis |
| Q70074141 | Effect of adding ketotifen to ipratropium bromide in the treatment of nocturnal asthma |
| Q39827584 | Effect of aerosol ipratropium bromide (SCH 1000) on sputum viscosity and volume in chronic bronchitis |
| Q57415823 | Effect of cessation of short-term therapy with ipratropium bromide on lung function and airway responsiveness |
| Q41646738 | Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial |
| Q72805462 | Effect of deep inspiration on Vmax in the normal control and patients with bronchial asthma--evaluation by the airway reversibility test with ipratropium bromide inhalation |
| Q36154134 | Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance |
| Q70535619 | Effect of freon inhalation on maximal expiratoryflows and heart rhythm after treatment with salbutamol and ipratropium bromide |
| Q44646297 | Effect of inhalation of salbutamol, beclomethasone dipropionate & ipratropium bromide on mucociliary clearance in some patients with chronic stable bronchial asthma |
| Q69296309 | Effect of inhaled ipratropium bromide on methacholine and exercise provocation in asthmatic children |
| Q68055630 | Effect of inhaled ipratropium bromide on the airway response to methacholine, histamine, and exercise in patients with mild bronchial asthma |
| Q72815924 | Effect of inhaled ipratropium bromide on tracheal mucociliary transport in bronchial asthma |
| Q42563756 | Effect of interactive ternary mixtures on dispersion characteristics of ipratropium bromide in dry powder inhaler formulations |
| Q70010049 | Effect of ipratropium bromide (atrovent) inhalation in chronic bronchitis |
| Q43629956 | Effect of ipratropium bromide aerosol on respiratory function in patients under ventilator treatment |
| Q72035163 | Effect of ipratropium bromide and/or sodium cromoglycate pretreatment on water-induced bronchoconstriction in asthma |
| Q67833724 | Effect of ipratropium bromide in bronchial asthma |
| Q45292624 | Effect of ipratropium bromide on EIB in children depends on vagal activity |
| Q43846748 | Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease. |
| Q39480391 | Effect of ipratropium bromide on airway mucociliary function |
| Q44073824 | Effect of ipratropium bromide on calcium activated potassium channel in tracheal smooth muscle cells from chronically hypoxic rats |
| Q43689148 | Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction |
| Q44564622 | Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease |
| Q36457548 | Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction |
| Q72835586 | Effect of ipratropium bromide on nasal mucociliary transport |
| Q69981668 | Effect of ipratropium bromide on repeated methacholine challenges |
| Q70039422 | Effect of ipratropium bromide on respiratory mechanics in infants with acute bronchiolitis |
| Q53941334 | Effect of ipratropium bromide on the action of bronchoactive agents. |
| Q48763319 | Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. |
| Q36123913 | Effect of lignocaine, sodium cromoglycate, and ipratropium bromide in exercise-induced asthma |
| Q54029622 | Effect of nebulized ipratropium bromide on intraocular pressures in children. |
| Q43685416 | Effect of nebulized ipratropium bromide on lung function in nonallergic bronchial asthma |
| Q36130293 | Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction |
| Q44533247 | Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis |
| Q93521593 | Effect of salbutamol, ipratropium bromide and cromolyn sodium on prostaglandin F2 alpha-induced bronchospasm |
| Q44577313 | Effect of single inhalation of a salbutamol, ipratropium bromide and beclomethasone on mucociliary clearance in patients with chronic obstructive airway disease. |
| Q68416947 | Effect of terfenadine and ipratropium bromide on ultrasonically nebulized distilled water-induced asthma |
| Q72800707 | Effect of the inhalation of an atropine derivative (ipratropium bromide) in powder form on respiratory mechanics in obstructive airway diseases |
| Q30468597 | Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial |
| Q72824382 | Effectiveness of disodium cromoglycate, salbutamol, and ipratropium bromide in the inhibition of exercise-induced bronchospasm |
| Q43699521 | Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD. |
| Q72826638 | Effects of 40 µg AND 400 µ of Ipratropium Bromide in Obstructive Lung Disease |
| Q72838712 | Effects of administration of a single dose of iprafen (l puff) compared with those of a single dose of ipratropium bromide (40 mcg.) and of fenoterol (100 mcg.) |
| Q72523795 | Effects of aerosol ipratropium bromide on cardiac vagal tone |
| Q36244089 | Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis |
| Q39400830 | Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study |
| Q42913473 | Effects of formoterol and ipratropium bromide on repeated cadmium inhalation-induced pulmonary inflammation and emphysema in rats |
| Q73662689 | Effects of high-dose ipratropium bromide and oral aminophylline on spirometry and exercise tolerance in COPD |
| Q51542002 | Effects of inhaled albuterol and ipratropium bromide on autonomic control of the cardiovascular system. |
| Q54105681 | Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD. |
| Q43870704 | Effects of inhaled ipratropium bromide on breathing mechanics and gas exchange in exercising horses with chronic obstructive pulmonary disease. |
| Q41119494 | Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema |
| Q72822514 | Effects of ipratropium bromide and fenoterol aerosols on exercise tolerance |
| Q39495536 | Effects of ipratropium bromide as a nebulized solution on respiratory function in mechanically ventilated patients |
| Q72771308 | Effects of ipratropium bromide in aerosol administration on airway resistance and MEFV curves |
| Q67547131 | Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma |
| Q72861643 | Effects of ipratropium bromide on bradykinin nasal provocation in chronic allergic rhinitis |
| Q70547416 | Effects of ipratropium bromide on lung mechanics in patients with irreversible airway obstruction. An indirect approach |
| Q71732547 | Effects of ipratropium bromide on pulmonary hemodynamics in COPD |
| Q96763617 | Effects of ipratropium bromide on the occurrence of postoperative respiratory complications in craniectomy patients with COPD: A nationwide multicenter retrospective study |
| Q44896020 | Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD |
| Q43241249 | Effects of salbutamol, ipratropium bromide and disodium cromoglycate on breathlessness induced by exercise in normal subjects |
| Q41825231 | Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease |
| Q83263279 | Effects on aerosol performance of mixing of either budesonide or beclomethasone dipropionate with albuterol and ipratropium bromide |
| Q36813641 | Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease |
| Q44766157 | Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma |
| Q80007585 | Efficacy and tolerance of high-dose inhaled ipratropium bromide vs. terbutaline in intubated premature human neonates |
| Q43621160 | Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis |
| Q53747228 | Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. |
| Q73947564 | Efficacy of ipratropium bromide by metered dose aerosol and aerochamber in acute paediatric bronchiolitis |
| Q38565068 | Efficacy of ipratropium bromide in acute childhood asthma: a meta-analysis |
| Q46809400 | Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease |
| Q45992870 | Efficacy of nebulized ipratropium bromide versus salbutamol in infants with acute bronchiolities. |
| Q46687907 | Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study |
| Q68056171 | Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosis |
| Q46879109 | Efficacy of salbutamol and ipratropium bromide in the management of acute bronchiolitis--a clinical trial |
| Q37701125 | Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered-Dose Inhaler |
| Q47643416 | Efficiency of a New Mesh-Type Nebulizer (NE-SM1 NEPLUS) for Intrapulmonary Delivery of Ipratropium Bromide in Surgical Patients |
| Q84579766 | Etiology. Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease |
| Q43511360 | Evaluation of the efficacy of the combination of fenoterol and ipratropium bromide (Duovent) in asthmatic subjects |
| Q70062380 | Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide |
| Q70551142 | Evidence of overadditive interaction between fenoterol and ipratropium bromide in the counteraction of cholinomimetic-induced tracheobronchial contractions |
| Q70026681 | Exercise-induced asthma (EIA): its prevention with the combined use of ipratropium bromide and fenoterol |
| Q36953965 | Exploratory economic evaluation of patients with COPD on a combination product versus individual components (ipratropium bromide and albuterol). |
| Q37343498 | Factors affecting the stability and performance of ipratropium bromide; fenoterol hydrobromide pressurized-metered dose inhalers |
| Q36166818 | Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children |
| Q72818454 | Fenoterol, ipratropium bromide and their combination in bronchial asthma |
| Q42048222 | First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department |
| Q77932034 | For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base |
| Q39826843 | Frequency effects of ipratropium bromide |
| Q70045335 | Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children |
| Q35596676 | Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD. |
| Q43287930 | Functional response to inhaled salbutamol and/or ipratropium bromide in Ascaris suum-sensitised cats with allergen-induced bronchospasms |
| Q54443994 | Hemodynamic effects of inhaled ipratropium bromide, alone and combined with an inhaled beta 2-agonist. |
| Q58805200 | High-performance liquid chromatographic assay for the simultaneous determination of ipratropium bromide, fenoterol, salbutamol and terbutaline in nebulizer solution |
| Q44812004 | Histamine-induced bronchial response after administration of placebo, salbutamol and a combination of a beta-2-adrenergic drug (fenoterol) with an anticholinergic agent (ipratropium bromide) in asymptomatic asthma patients |
| Q88814503 | IPRATROPIUM BROMIDE FOR ACUTE ASTHMA IN CHILDREN: A RETROSPECTIVE TRIAL |
| Q39909561 | Immunological release of histamine from human lung. II. Studies on acetylcholine and the anticholinergic agent ipratropium bromide |
| Q43595791 | Improved delivery of fenoterol plus ipratropium bromide using Respimat compared with a conventional metered dose inhaler |
| Q73928556 | Improved delivery of ipratropium bromide using Respimat (a new soft mist inhaler) compared with a conventional metered dose inhaler: cumulative dose response study in patients with COPD |
| Q43972267 | In children hospitalized for asthma exacerbations, does adding ipratropium bromide to albuterol and corticosteroids improve outcome? |
| Q73724348 | Individual results of treatment of COPD with low doses of fenoterol compared with treatment with ipratropium bromide |
| Q35117612 | Ineffectiveness of ipratropium bromide in acute bronchiolitis |
| Q69983770 | Influence of 0.2 mg ipratropium bromide on mucociliary clearance in patients with chronic bronchitis |
| Q69979420 | Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma |
| Q67666825 | Influence of antihistamine (astemizole) and anticholinergic drugs (ipratropium bromide) on bronchoconstriction induced by substance P |
| Q47280266 | Influence of crystal form of ipratropium bromide on micronisation and aerosolisation behaviour in dry powder inhaler formulations |
| Q54198618 | Influence of lung function and postnatal age on the response to nebulized ipratropium bromide in children born prematurely. |
| Q51095233 | Inhalable Ipratropium Bromide Particle Engineering with Multicriteria Optimization. |
| Q37693967 | Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease |
| Q43732336 | Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease |
| Q83332529 | Inhaled formoterol versus ipratropium bromide in chronic obstructive pulmonary disease |
| Q70726793 | Inhaled ipratropium bromide and terbutaline in asthmatic children |
| Q24241986 | Inhaled ipratropium bromide for stable chronic obstructive pulmonary disease |
| Q24241991 | Inhaled ipratropium bromide for stable chronic obstructive pulmonary disease |
| Q68057076 | Inhibition of gustatory rhinorrhoea by intranasal ipratropium bromide |
| Q34403136 | Inhibition of inhaled metabisulphite-induced bronchoconstriction by inhaled frusemide and ipratropium bromide |
| Q34446527 | Inhibition of methoxamine-induced bronchoconstriction by ipratropium bromide and disodium cromoglycate in asthmatic subjects |
| Q42086952 | Internal medicine: use of ipratropium bromide in chronic obstructive pulmonary disease. |
| Q72794843 | Intranasal ipratropium bromide for paroxysmal rhinorrhoea |
| Q24201895 | Intranasal ipratropium bromide for the common cold |
| Q24235444 | Intranasal ipratropium bromide for the common cold |
| Q24241392 | Intranasal ipratropium bromide for the common cold |
| Q46620958 | Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia |
| Q39783973 | Ipratropium Bromide, an Anticholinergic Bronchodilator/Behavior of airways resistance in patients with reversible respiratory obstruction following inhalation of various doses of ipratropium bromide |
| Q68057120 | Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine |
| Q69992340 | Ipratropium bromide (Atrovent) as inhalation powder. A double-blind study of comparison with ipratropium as a pressure aerosol in patients with reversible airways obstruction |
| Q69294542 | Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study |
| Q71573137 | Ipratropium bromide (Atrovent) nasal spray. A new treatment for rhinorrhea |
| Q66840447 | Ipratropium bromide (Sch1000) monohydrate aerosol: Bronchodilator effect of three dose levels in asthmatics |
| Q36178749 | Ipratropium bromide HFA. |
| Q57529027 | Ipratropium bromide added to asthma treatment in the pediatric emergency department |
| Q39834796 | Ipratropium bromide aerosol in chronic bronchitis |
| Q42995470 | Ipratropium bromide and airways function in wheezy infants |
| Q39172518 | Ipratropium bromide and airways obstruction in childhood |
| Q39563156 | Ipratropium bromide and fenoterol by aerosolized solution |
| Q39881252 | Ipratropium bromide and fenoterol in pulmonary tuberculosis |
| Q72347489 | Ipratropium bromide and intraoperative bronchospasm |
| Q44088718 | Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology |
| Q72774140 | Ipratropium bromide bronchodilator solution |
| Q67899000 | Ipratropium bromide delivered by metered-dose aerosol to infant wheezers |
| Q34403195 | Ipratropium bromide delivered orally by metered dose inhaler does not decrease salivary flow in normal subjects |
| Q37615849 | Ipratropium bromide for acute asthma exacerbations in the emergency setting: a literature review of the evidence |
| Q24194933 | Ipratropium bromide for stable chronic obstructive pulmonary disease |
| Q24234151 | Ipratropium bromide for stable chronic obstructive pulmonary disease |
| Q67904877 | Ipratropium bromide for symptomatic preterm infants |
| Q44551456 | Ipratropium bromide for treatment of bethanechol-induced sialorrhea |
| Q43760000 | Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD. |
| Q39486788 | Ipratropium bromide in COPD and asthma |
| Q70557024 | Ipratropium bromide in acute asthma |
| Q51704416 | Ipratropium bromide in acute asthma exacerbation. |
| Q34777702 | Ipratropium bromide in acute asthma. |
| Q77765662 | Ipratropium bromide in acute asthma: small beneficial effects? |
| Q39480412 | Ipratropium bromide in asthma. A review of the literature |
| Q68055404 | Ipratropium bromide in asthmatic crisis in infants |
| Q36118194 | Ipratropium bromide in children with asthma |
| Q39480425 | Ipratropium bromide in chronic bronchitis/emphysema. A review of the literature |
| Q39783968 | Ipratropium bromide in controlled clinical trials. Short communication (II): Time-response measurements of pulmonary function after ipratropium bromide and isoprenaline |
| Q73390959 | Ipratropium bromide in emergency management of acute asthma exacerbation |
| Q93929275 | Ipratropium bromide in emergency management of acute asthma exacerbation |
| Q36705555 | Ipratropium bromide in patients with nocturnal asthma |
| Q36723058 | Ipratropium bromide in the management of chronic obstructive pulmonary disease: effect on health service expenditures |
| Q77956819 | Ipratropium bromide in the recovery phase after methacholine PD20: is there more than an antagonist effect? |
| Q70061941 | Ipratropium bromide in the treatment of the 'rhinorrhoea syndrome' |
| Q42633838 | Ipratropium bromide increases the ability of the nose to warm and humidify air. |
| Q72770262 | Ipratropium bromide induced angle closure glaucoma |
| Q73228117 | Ipratropium bromide induced unilateral mydriasis |
| Q70540003 | Ipratropium bromide inhalation for allergic rhinitis and chronic cough |
| Q42053700 | Ipratropium bromide is more effective than Salmeterol - Fluticason combination on O2 saturation patients with COPD. |
| Q70699562 | Ipratropium bromide nasal spray |
| Q39439426 | Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis |
| Q39442329 | Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial |
| Q39416772 | Ipratropium bromide nasal spray for treatment of rhinorrhea in the laryngectomized patient: a pilot study. |
| Q53655883 | Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. |
| Q72535277 | Ipratropium bromide nebulizer therapy and airway submucosal gland secretion |
| Q43517116 | Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma |
| Q46986122 | Ipratropium bromide potentiates bronchoconstriction induced by vagal nerve stimulation in the guinea-pig |
| Q51646278 | Ipratropium bromide protects against bronchoconstriction during bronchoscopy. |
| Q44104659 | Ipratropium bromide solution |
| Q81312798 | Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease |
| Q30451729 | Ipratropium bromide treatment of experimental rhinovirus infection |
| Q24245413 | Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease |
| Q24246490 | Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease |
| Q39863183 | Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis |
| Q40217598 | Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis |
| Q68157401 | Ipratropium bromide: an additive effect? |
| Q42719428 | Ipratropium bromide: analytical methods |
| Q36724112 | Ipratropium bromide: are patients treated with optimal therapy? |
| Q44991775 | Ipratropium bromide: bronchodilator action and effect on methacholine-induced bronchoconstriction |
| Q42719427 | Ipratropium bromide: drug metabolism and pharmacokinetics |
| Q42719429 | Ipratropium bromide: methods of chemical and biochemical synthesis |
| Q39823494 | Ipratropium bromide: mucociliary clearance rate and airway resistance in normal subjects |
| Q42719430 | Ipratropium bromide: physical properties |
| Q80149822 | Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients? |
| Q35533694 | Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease |
| Q43627704 | Localization of bronchial response to ipratropium bromide by respiratory impedance measurement in asthmatics |
| Q39898576 | Long term effect of ipratropium bromide on gastric secretion |
| Q50999223 | Long-Term Efficacy and Safety of Ipratropium Bromide plus Fenoterol via Respimat((R)) Soft Misttrade mark Inhaler (SMI) versus a Pressurised Metered-Dose Inhaler in Asthma. |
| Q93530144 | Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma |
| Q72530735 | Long-term ipratropium bromide nebuliser therapy and lung mucociliary clearance |
| Q28329938 | Long-term safety and efficacy study of intranasal ipratropium bromide |
| Q72239900 | Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06% |
| Q45208385 | Lung function and exercise tolerance after treatment with salmeterol or ipratropium bromide in chronic obstructive pulmonary disease |
| Q46571894 | Magnesium sulfate versus ipratropium bromide in chronic obstructive pulmonary disease exacerbation: a randomized trial |
| Q33253272 | Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particles |
| Q72763683 | Maximal Expiratory Flows and Forced Vital Capacity in Normal, Asthmatic and Bronchitic Subjects after Salbutamol and Ipratropium Bromide |
| Q44583460 | Meconium ileus equivalent in association with nebulised ipratropium bromide in cystic fibrosis |
| Q44682227 | Meta-analysis of the effects of ipratropium bromide in adults with acute asthma |
| Q92598776 | Metered-dose inhaler ipratropium bromide for children with acute asthma exacerbation: A prospective, non-randomized, observational study |
| Q53497909 | Metered-dose inhaler ipratropium bromide in moderate acute asthma in children: A single-blinded randomised controlled trial. |
| Q72587164 | Nebulised ipratropium bromide and salbutamol causing closed-angle glaucoma |
| Q70538822 | Nebulised ipratropium bromide and salbutamol in chronic bronchitis |
| Q35117690 | Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life |
| Q54507812 | Nebulised ipratropium bromide in wheezy infants and young children |
| Q47583241 | Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction |
| Q91436856 | Nebulized Ipratropium bromide protects against tracheal and bronchial secretion during bronchoscopy: A randomized controlled trial |
| Q91195911 | Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double-blind Controlled Trial |
| Q33669723 | Nebulized ipratropium bromide in acute pediatric asthma: does it reduce hospital admissions among children presenting to the emergency department? |
| Q69864324 | Nebulized ipratropium bromide in the treatment of acute asthma |
| Q64930385 | Nebulized ipratropium bromide in ventilator-assisted patients with chronic bronchitis. |
| Q42203503 | Nebulized salbutamol and ipratropium bromide in asthmatic children |
| Q73635546 | Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma |
| Q71652096 | Olfactory stimuli provoke diffuse esophageal spasm: reversal by ipratropium bromide |
| Q46092678 | One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease |
| Q72018477 | Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions |
| Q39794065 | Onset of action and maximum effect of bronchodilators administered by a metered dose inhaler. Clinical investigations with fenoterol, hexoprenaline, ipratropium bromide, isoprenaline, orciprenaline, salbutamol and terbutaline (author's transl) |
| Q72757132 | Oxitropium bromide, ipratropium bromide and fenoterol in exercise-induced asthma |
| Q46514840 | PVC membrane electrode for the potentiometric determination of Ipratropium bromide using batch and flow injection techniques |
| Q67834177 | Paradoxic bronchial constriction after inhalation of fenoterol and ipratropium bromide |
| Q55510524 | Paradoxical bronchoconstriction in wheezing infants after nebulised ipratropium bromide: Authors' reply. |
| Q54297604 | Paradoxical response to nebulized ipratropium bromide in pre-term infants asymptomatic at follow-up |
| Q69301830 | Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration |
| Q64883597 | Pharmacologic anisocoria due to nebulized ipratropium bromide: A diagnostic challenge. |
| Q84738870 | Pharmacologic unilateral mydriasis due to nebulized ipratropium bromide |
| Q46810962 | Pharmacological mydriasis secondary to ipratropium bromide: a cause of unilateral dilated pupil |
| Q41842208 | Plethysmography and impulse oscillometry assessment of tiotropium and ipratropium bromide; a randomized, double-blind, placebo-controlled, cross-over study in healthy subjects |
| Q43751080 | Prevention of fog-induced bronchospasm by Duovent and its components (fenoterol, ipratropium bromide) in asthmatics |
| Q43694383 | Prevention of fog-induced bronchospasm by high doses of ipratropium bromide in asthmatics |
| Q72239892 | Product characteristics and pharmacokinetics of intranasal ipratropium bromide |
| Q72807223 | Protection by ipratropium bromide and metaproterenol against methacholine and histamine bronchoconstriction |
| Q39881280 | Protective and bronchospasmolytic effect of ipratropium bromide in bronchial antigen challenge tests compared to other antiasthmatic drugs |
| Q72794850 | Protective effect of fenoterol spray, ipratropium bromide plus fenoterol spray, and oral clenbuterol, on exercise-induced asthma in children. Double blind controlled and randomized clinical trial |
| Q45304109 | Protective effect of ipratropium bromide on bronchoconstriction induced by sulfur dioxide exposure during apricot sufurization processes that causes asthma-like syndrome in agricultural environment |
| Q68057343 | Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma |
| Q54359417 | Pulmonary effects of sulfur dioxide exposure and ipratropium bromide pretreatment in adults with nonallergic asthma. |
| Q74281634 | Pulmonary function profile in chronic congestive heart failure and the effect of ipratropium bromide |
| Q70212755 | Pulmonary responses of salbutamol tolerant guinea-pigs to aminophylline and ipratropium bromide |
| Q51864716 | Quantification of the synergism between fenoterol and ipratropium bromide in the counteraction of experimental bronchospasm. |
| Q31031984 | Quantitative analysis of a quaternary ammonium drug: ipratropium bromide by LC/ESI-MS(n) in horse plasma and urine |
| Q46368621 | Radioreceptor assay for determination of the antimuscarinic drug ipratropium bromide in man. |
| Q79985680 | Radioreceptor assays of ipratropium bromide in plasma and urine |
| Q54120067 | Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. |
| Q51100434 | Randomized controlled trial of ipratropium bromide and salbutamol versus salbutamol alone in children with acute exacerbation of asthma. |
| Q39587121 | Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation |
| Q42042103 | Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department |
| Q68408500 | Relative efficacy of nebulised ipratropium bromide and fenoterol in acute severe asthma |
| Q73925722 | Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients |
| Q67600327 | Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide |
| Q44011344 | Response to nebulized ipratropium bromide and terbutaline in acute severe asthma |
| Q47859202 | Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma |
| Q33715834 | Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease. |
| Q42582671 | Reversed phase-high performance liquid chromatographic (RP-HPLC) method to measure migration of semi-volatile compound, vanillin, in ipratropium bromide inhalation solution |
| Q39480398 | Review of ipratropium bromide in induced bronchospasm in patients with asthma |
| Q59510346 | Review: beta-agonists plus ipratropium bromide improve airflow obstruction in adults with acute asthma |
| Q51217647 | Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: a nested case-control study. |
| Q43486031 | Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study. |
| Q73564848 | Role of nebulized ipratropium bromide in acute exacerbation of early chronic obstructive airway disease |
| Q45932644 | Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children. |
| Q72794856 | Salbutamol versus Duovent (a combination of fenoterol and ipratropium bromide) in asthma |
| Q70061571 | Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma? |
| Q33603543 | Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma |
| Q39286771 | Site of bronchodilatation with inhaled ipratropium bromide and fenoterol in normal subjects |
| Q36453616 | Sodium cromoglycate and ipratropium bromide in exercise-induced asthma |
| Q58282951 | Spectrophotometric Determination of Ipratropium Bromide in Liquid for Nebulization |
| Q72822356 | Sputum Changes Associated with the Use of Ipratropium Bromide |
| Q72526638 | Sputum viscosity and long-term ipratropium bromide nebuliser therapy |
| Q58805194 | Stability of ipratropium bromide and salbutamol nebuliser admixtures |
| Q69298286 | Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD |
| Q77334151 | Standard dose of inhaled albuterol significantly increases QT dispersion compared to low dose of albuterol plus ipratropium bromide therapy in moderate to severe acute asthma attacks in children |
| Q85648472 | Stimulation of suicidal erythrocyte death by ipratropium bromide |
| Q57616974 | Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease |
| Q70026692 | Studies of ipratropium bromide and fenoterol administered by metered-dose inhaler and aerosolized solution |
| Q72818361 | Studies on airway reversibility test by ipratropium bromide (Sch 1000) inhalation using partial and maximum expiratory flow-volume curve |
| Q39784005 | Studies on the pharmacokinetics and biotransformation of ipratropium bromide in the rat and dog |
| Q54015885 | Study of ipratropium bromide inhalation in stable asthma. |
| Q28377143 | Styrofoam cup, ipratropium bromide, and anisocoria |
| Q28341999 | Supraventricular tachycardia caused by nebulised ipratropium bromide |
| Q70558493 | The acute effect of ipratropium bromide bronchodilator therapy on cough clearance in COPD |
| Q72588727 | The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD |
| Q74415111 | The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis |
| Q69989681 | The bronchodilator effect of a fixed-combination metered aerosol (fenoterol and ipratropium bromide) |
| Q39888648 | The bronchospasmolytic and protective effects of fenoterol, ipratropium bromide, theophylline ethylenediamine and disodium cromoglicicum in inhalation challenge tests; a comparative study (author's transl) |
| Q70026642 | The combination of fenoterol and ipratropium bromide in bronchial asthma: comparison of the acute effects of two different dosages |
| Q33829906 | The compatibility between packing material and ipratropium bromide aerosol |
| Q51640800 | The current role of ipratropium bromide in an acute exacerbation of asthma. |
| Q70061569 | The duration of action of the combination of fenoterol hydrobromide and ipratropium bromide in protecting against asthma provoked by hyperpnea |
| Q77194117 | The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials |
| Q44096486 | The effect of administrative cessation of the use of ipratropium bromide in the treatment of acute asthma attacks in the emergency department |
| Q36453706 | The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis |
| Q72911419 | The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis |
| Q68437575 | The effect of inhaled fenoterol and ipratropium bromide on propranolol induced bronchoconstriction in the asthmatic airways |
| Q68298911 | The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5'-monophosphate and histamine in asthma |
| Q67918141 | The effect of ipratropium bromide (Atrovent) on the air conditioning capacity of the nose |
| Q57557628 | The effect of ipratropium bromide on intraocular pressure in patients with chronic obstructive pulmonary disease: an open-label study |
| Q43417071 | The effect of ipratropium bromide on lung function in patients with cystic fibrosis |
| Q68057470 | The effect of ipratropium bromide on maximal exercise capacity in asthmatic and non-asthmatic men |
| Q43832442 | The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study |
| Q47683983 | The effect of ventilator mask atomization inhalation of ipratropium bromide and budesonide suspension liquid in the treatment of COPD in acute exacerbation period on circulating levels of inflammation and prognosis |
| Q51839080 | The effects of chronic inhalation of salbutamol on the acute airway responsiveness to salbutamol and ipratropium bromide in the conscious and the anaesthetized guinea-pig. |
| Q68419151 | The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients |
| Q42126604 | The effects of ipratropium bromide and fenoterol nebulizer solutions in children with asthma |
| Q74348613 | The effects of ipratropium bromide on histamine-induced bronchoconstriction in subjects with cervical spinal cord injury |
| Q39881276 | The effects of ipratropium bromide on the histamine inhalation challenge in asthmatic and bronchitic patients |
| Q34417954 | The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma |
| Q39365981 | The influence of ipratropium bromide in the recovery phase of methacholine induced-bronchospasm. |
| Q42036174 | The influence of terfenadine and ipratropium bromide alone and in combination on bradykinin-induced nasal symptoms and plasma protein leakage |
| Q69295636 | The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF |
| Q66942704 | The protective effect of fenoterol, ipratropium bromide and amitriptyline against induced bronchial spasm (author's transl) |
| Q70567518 | The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine |
| Q71995586 | The protective effects of ipratropium bromide and terbutaline on distilled water-induced bronchoconstriction |
| Q30724253 | The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. |
| Q39464686 | The separation of ipratropium bromide and its related compounds |
| Q34443155 | The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: a systematic review. |
| Q24187073 | Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease |
| Q24198068 | Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease |
| Q24204005 | Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease |
| Q43178264 | Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Nebulised ipratropium bromide and bronchiolitis |
| Q50183322 | Transient anisocoria caused by aerosolized ipratropium bromide exposure from an ill-fitting face mask |
| Q67545864 | Treatment of acute wheezing and dyspnea attacks in children under 2 years old: inhalation of fenoterol plus ipratropium bromide versus fenoterol |
| Q42203901 | Treatment of asthma bronchiale with a combination of ipratropium bromide and fenoterol |
| Q38378868 | Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study |
| Q33151586 | Treatment of recurrent neurocardiogenic syncope with cardiac inhibitors with ipratropium bromide |
| Q43868710 | Ultrasonic spray protection against bronchospasm. Comparison of fenoterol and a combination of salbutamol and ipratropium bromide |
| Q69890843 | Unilateral fixed dilated pupil associated with nebulised ipratropium bromide |
| Q73506063 | Unilateral fixed dilated pupil in an infant after inhalation of nebulized ipratropium bromide |
| Q42107782 | Unilateral mydriasis secondary to ipratropium bromide in a critically ill patient. |
| Q38422247 | Unilateral pupillary mydriasis from nebulized ipratropium bromide: A false sign of brain herniation in the intensive care unit |
| Q28326658 | Urinary Retention Associated with Ipratropium Bromide |
| Q42647552 | Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies |
| Q72755553 | Use of Ipratropium Bromide in Patients with Severe Airways Obstruction |
| Q39839468 | Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline |
| Q71953603 | Use of ipratropium bromide by inhalation in the treatment of acute asthma in children. Clinical experience |
| Q70019037 | Use of ipratropium bromide in asthma. Results of a multi-clinic study |
| Q39489915 | Use of ipratropium bromide in obstructive lung disease. |
| Q71693339 | Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications |
| Q73060480 | Vagal activity and airway response to ipratropium bromide before and after exercise in ambient and cold conditions in healthy cross-country runners |
| Q68425335 | Vasomotor rhinitis and the systemic absorption of ipratropium bromide |
| Q39119703 | Whole-body plethysmographic studies on the bronchospasmolytic effect of 2 antiasthmatic drug combinations and ipratropium bromide |
| Q70018671 | [A combination of fenoterol and ipratropium bromide administered by inhalation. Evaluation of its effectiveness and tolerance in a long-term study] |
| Q71055372 | [A trial of ipratropium bromide dose optimalization in patients with atopic asthma] |
| Q73955316 | [Acute closure-angle glaucoma after treatment with ipratropium bromide and salbutamol aerosols] |
| Q77912645 | [Acute glaucoma in the course of treatment with aerosols of ipratropium bromide and salbutamol] |
| Q54529273 | [Antagonistic effects of ipratropium bromide on bronchial hypertonia induced with beta-blocking agents] |
| Q70536638 | [Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)] |
| Q70517853 | [Clinical, electrocardiographic and electrophysiologic evaluation of intravenous and oral ipratropium bromide in patients with symptomatic bradycardia] |
| Q70526740 | [Comparative effects of terbutaline sulphate and ipratropium bromide on the respiratory system (author's transl)] |
| Q69997149 | [Comparative study of the bronchodilating action of fenoterol and ipratropium bromide administered by aerosols in acute attacks of asthma] |
| Q74288687 | [Comparing the bronchodilating effects of ipratropium bromide and theophylline] |
| Q72161440 | [Comparison of the influence of ipratropium bromide and salbutamol on activity of phosphocreatine kinase (CK) and isoenzyme CK-MB] |
| Q73822937 | [Degree and duration of bronchodilatation with an agonist beta 2 administered alone versus an agonist beta 2 administered with ipratropium bromide in children with acute asthma] |
| Q70007958 | [Effect of Atrovent (ipratropium bromide) on the mechanics of respiration in patients with chronic obstructive pulmonary disease] |
| Q72781234 | [Effect of fenoterol, ipratropium bromide and combination drug-berodual-on selected clinical parameters and lung function in patients with asthma] |
| Q69319342 | [Effect of fenoterol, ipratropium bromide and their combination--Berodual--on pulmonary ventilation in patients with asthma] |
| Q74247710 | [Effect of inhalation of ipratropium bromide on nonspecific esophageal motility disturbance--case report] |
| Q70532792 | [Effect of ipratropium bromide (Sch 1000) on the action of various bronchoactive agents (author's transl)] |
| Q72161444 | [Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma] |
| Q54342336 | [Effects of ipratropium bromide (IPB) and its combination with salbutamol sulfate (SAS) in acute asthmatic attack]. |
| Q54329720 | [Effects of ipratropium bromide and salbutamol on isolated lung hyperinflation in symptom-free intervals in asthmatic children] |
| Q73204161 | [Efficacy of early administration of nebulized ipratropium bromide in children with asthmatic crisis] |
| Q72160953 | [Evaluation of the bronchodilatory activity of berodual and its components: fenoterol and ipratropium bromide in children with bronchial asthma] |
| Q73273374 | [Experiences in therapy of bradycardic cardiac arrhythmias in childhood with ipratropium bromide] |
| Q72784692 | [Fenoterol, ipratropium bromide and their combination in the therapy of bronchospasm] |
| Q70561947 | [Heart rate behaviour and hemodynamics after oral therapy with ipratropium bromide in patients with sinus bradycardia (author's transl)] |
| Q72796481 | [Hemodynamic effects of ipratropium bromide in comparison with atrial stimulation] |
| Q68420630 | [Inhalation bronchodilators in infancy--comparative study between salbutamol and ipratropium bromide] |
| Q73767041 | [Inhalation of high-doses of ipratropium bromide (Atrovent) does not cause any changes in systemic or pulmonary hemodynamics] |
| Q72125723 | [Ipratropium bromide in COPD. Cost effectiveness of the treatment of COPD with ipratropium bromide] |
| Q74209270 | [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?] |
| Q54073519 | [Modification in some nasal function parameters after metacholine stimulation and pretreatment with ipratropium bromide] |
| Q72601818 | [Pharmacological prevention of exercise-induced bronchospasm: review of the literature and trial of disodium cromoglycate, fenoterol and ipratropium bromide in a pediatric population] |
| Q67280764 | [Possibility of prevention of histamine-induced bronchospastic reaction with fenoterol, ipratropium bromide and lidocaine in patients with chronic bronchitis] |
| Q54547870 | [Suppression of non-specific bronchial hyperreactivity by DSCG (Disodium cromoglycate) and ipratropium bromide (author's transl)] |
| Q72779867 | [The bronchodilator action of berodual spray compared to fenoterol and ipratropium bromide sprays] |
| Q77577838 | [The effect of inhaled ipratropium bromide on airway and lung tissue muscarinic receptors in a rat model of COPD] |
| Q72160949 | [The effect of inhaling pirenzepine--selective M1 receptor antagonist and ipratropium bromide on lung ventilation in patients with bronchial asthma] |
| Q70538296 | [The effect of ipratropium bromide on ciliary action (author's transl)] |
| Q70008370 | [Vagal component in bronchial constriction induced by histamine: effect of ipratropium bromide] |
| Q72191484 | [Value of ipratropium bromide in asthma crisis in children] |
| Q77334651 | [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?] |
| Category:Ipratropium bromide | wikimedia | |
| Arabic (ar / Q13955) | إبراتروبيوم بروميد | wikipedia |
| azb | ایپراتروپیوم بروماید | wikipedia |
| Ipratropium | wikipedia | |
| Ipratropiumbromid | wikipedia | |
| Ιπρατρόπιο | wikipedia | |
| Ipratropium bromide | wikipedia | |
| Ipratropio | wikipedia | |
| Basque language (eu / Q8752) | Ipratropio | wikipedia |
| Persian (fa / Q9168) | ایپراتروپیوم بروماید | wikipedia |
| Ipratropium | wikipedia | |
| Bromure d'ipratropium | wikipedia | |
| איפראטרופיום | wikipedia | |
| hi | इप्राट्रोपियम ब्रोमाइड | wikipedia |
| Ipratropium | wikipedia | |
| Իպրատրոպիում բրոմիդ | wikipedia | |
| Ipratropium bromida | wikipedia | |
| Ipratropio | wikipedia | |
| イプラトロピウム | wikipedia | |
| mk | Ипратропиум бромид | wikipedia |
| or | ଇପ୍ରାଟ୍ରୋପିଅମ ବ୍ରୋମାଇଡ | wikipedia |
| Bromek ipratropiowy | wikipedia | |
| Ipratrópio | wikipedia | |
| Ипратропия бромид | wikipedia | |
| Serbo-Croatian (sh / Q9301) | Ipratropijum | wikipedia |
| Ipratropijum | wikipedia | |
| Іпратропію бромід | wikipedia | |
| Ipratropium bromide | wikipedia | |
| 異丙托溴銨 | wikipedia |
Search more.